Director of the Institute of Toxicology and Pharmacology at the University of Rostock
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"Cannabinoids, in addition to having palliative benefits in cancer therapy, have been associated with anticarcinogenic effects. Cannabinoids may... offer a therapeutic option in the treatment of highly invasive cancers."
"Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1", Journal of the National Cancer Institute, Dec. 25, 2007
Experts PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Director, Institute of Toxicology and Pharmacology, University of Rostock
Former Researcher, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg